Consistent with a potential role in cancer, SMARCD3 was highly expressed in end-stage primary tumors from KPf/fC mice, an aggressive model of pancreatic cancer driven by p53 deletion24 (Fig. 1e). This evidence concerns the gene TP53 and cancer.